Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kevin Michael Coveney Insider Profile
4 Followers
Kevin Michael Coveney, CFO at Enveric Biosciences, holds 186.50K shares in Enveric Biosciences (Ticker: ENVB).
Kevin Michael Coveney has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Kevin Michael Coveney's holdings
Insider Roles
CFO
Roles that Kevin Michael Coveney holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kevin Michael Coveney
Kevin Michael Coveney's Trading History
List of latest transactions for each holding click on a transaction to see Kevin Michael Coveney's performance on stock
You May Also Like
Kevin Michael Coveney insider profile FAQ
What is the percentage of profitable transactions made by Kevin Michael Coveney?
The percentage of profitable transactions made by Kevin Michael Coveney is ―.
What is the average return per transaction made by Kevin Michael Coveney?
The average return per transaction made by Kevin Michael Coveney is ―.
What stocks does Kevin Michael Coveney hold?
Kevin Michael Coveney holds: ENVB stocks.
What was Kevin Michael Coveney’s latest transaction?
Kevin Michael Coveney latest transaction was an Uninformative Buy of ―.
What was Kevin Michael Coveney's most profitable transaction?
Kevin Michael Coveney’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kevin Michael Coveney's role in Enveric Biosciences?
Kevin Michael Coveney's role in Enveric Biosciences is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.